Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Catherine Rheaume
Introduction
Catherine Rheaume is a notable inventor based in Irvine, California. She has made significant contributions to the field of biomedical research, particularly in the detection of specific proteins related to neurological conditions. Her work has implications for understanding and diagnosing various diseases.
Latest Patents
Catherine Rheaume holds a patent for a "Method of detecting cleaved SNAP25 in tissue samples." This invention describes methods and compositions for detecting BoNT/A enzymatic activity in tissues or tissue samples. The invention encompasses antibodies that bind preferentially to BoNT/A cleaved SNAP25, allowing for the detection of cleaved SNAP25 in a tissue sample, as compared to intact (non-cleaved) SNAP25.
Career Highlights
Catherine is currently employed at Allergan, Inc., where she continues to advance her research and innovations. Her work at Allergan has positioned her as a key player in the development of diagnostic tools that can enhance patient care.
Collaborations
Catherine has collaborated with esteemed colleagues such as Ron S. Broide and Brian Cai. These collaborations have fostered a productive environment for innovation and research in her field.
Conclusion
Catherine Rheaume's contributions to the field of biomedical research exemplify the impact of innovative thinking in healthcare. Her patent and ongoing work at Allergan, Inc. highlight her commitment to advancing medical science and improving diagnostic methods.